City of Hope Comprehensive Cancer Center
Duarte, California, 91010-3000, United States
NCT Number: NCT00807404
RATIONALE: New diagnostic procedures, such as optical coherence tomography, may be effective in finding tumor cells.
PURPOSE: This clinical trial is studying optical coherence tomography in tissue samples from women undergoing mastectomy for the treatment or prevention of breast ductal intraepithelial neoplasia.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Duarte, California, 91010-3000, United States
OBJECTIVES:
OUTLINE: Breast tissue samples are obtained during mastectomy and analyzed ex-vivo by optical coherence tomography (OCT) and by histopathological examination. Once routine pathological evaluation and tissue sampling are completed, OCT imaging is performed using a portable forward imaging needle probe that is inserted through the ducts of the tissue sample. OCT images of the surface of the closest margin to the tumor (if present) as well as images of the duct(s) in the nipple areola complex (after dilation) are obtained. Images of a cross section of the tumor (after the sample has been sliced by the pathologist) are also obtained. The OCT images are then correlated with tissue histology. The images are used to create a correlation histology-OCT atlas for the evaluation of subsequent images and for future reference.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
City of Hope Medical Center
Other
Forward Image Guided Ductoscopy for Early Cancer Screening
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01302834
Carcinoma, Carcinoma, Squamous Cell
Anchorage, Alaska, United States
View Trial DetailsNCT00625066
Colonic Diseases, Colonic Neoplasms
Nashville, Tennessee, United States
View Trial DetailsNCT00769587
Immune System Diseases, Mast Cell Activation Disorders
Amiens, France
View Trial DetailsNCT00357682
Barrett Esophagus, Digestive System Diseases
View Trial Details